Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell Disorders
Clinical trial NCT07365059 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07365059
- Sponsor
- Qi deng
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-25
- Primary completion
- 2029-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.